Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1991
04/02/1991US5004805 Hepatocyte growth factor
04/02/1991US5004804 Method and composition for preparation of factor VIIIC
04/02/1991US5004803 Recombinant dna coding for factor VIII in which its B domain is replaced with a peptide sequence of factor V
04/02/1991US5004802 100KDa protein from blood which binds to and inhibits the activity of plasminogen activators
04/02/1991US5004741 Cholecystokinin(CCK); Treating Disorders Of The Gastrointestinal Tract, Central Nervous System And Of The Appetite Of Animals
04/02/1991US5004728 Administering somatotropin and supplementing with ling chain fatty acid or salt
04/02/1991US5004697 Cationized antibodies for delivery through the blood-brain barrier
04/02/1991US5004694 Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies
04/02/1991US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides
04/02/1991US5004689 DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
04/02/1991US5004609 Fibrinophilic urokinase complex
04/02/1991US5004605 Low pH pharmaceutical compositions of recombinant β-interferon
04/02/1991US5004604 Incubating animal cells with antibodies which coat them, washing, injecting into animal, collecting blood, separating serum
04/02/1991US5004602 Continuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide
04/02/1991CA1282550C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
04/02/1991CA1282549C Aminocarbonyl renin inhibitors
04/02/1991CA1282356C INTERFERON .alpha. 76
04/02/1991CA1282355C INTERFERON .alpha. 61
04/02/1991CA1282354C INTERFERON .alpha. 54
04/02/1991CA1282353C INTERFERON .alpha. 74
04/02/1991CA1282324C COMPOSITIONS FOR STIMULATING INTERGUMENTAL MELANOCYTES BY TOPICAL APPLICATIONOF ANALOGS OF .alpha.-MSH AND COMPOSITIONS FOR USE IN SAME
03/1991
03/31/1991CA2026468A1 Human endothelin-3 cdna and use thereof
03/30/1991WO1991005258A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991WO1991004746A1 Anti-thrombotic peptides and pseudopeptides
03/30/1991CA2066674A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2066047A1 Anti-thrombotic peptides and pseudopeptides
03/30/1991CA2026453A1 Mutein of acidic fgf, and its production
03/30/1991CA2026166A1 Medicamentous form
03/30/1991CA2025155A1 Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer
03/29/1991CA2026404A1 Method of increasing specific activity of t-pa
03/29/1991CA2026382A1 Inhibitors of retroviral proteases
03/29/1991CA2026149A1 Stabilized aqueous formulations of small peptides
03/29/1991CA2025530A1 Porcine lactoferrin amino acid and cdna sequence and methods
03/29/1991CA2024046A1 Stabilized leukocyte-interferons
03/28/1991WO1991004745A1 Compositions for cell adhesion inhibition and methods of use
03/28/1991DE3936594A1 (gamma)-glutamyl-transferasen zur behandlung von krankheiten (Gamma) glutamyl-transferases for treating diseases
03/28/1991CA2067183A1 Compositions for cell adhesion inhibition and methods of use
03/28/1991CA2026283A1 Oral pharmaceutical composition for acid sensitive proteinaceous agents
03/28/1991CA2025857A1 Antitumor composition
03/27/1991EP0419327A1 Amino acid derivatives, method for their preparation and their therapeutic application
03/27/1991EP0419298A1 Immunostimulating proteins, monoclonal and polyclonal corresponding antibodies, corresponding hybridoma and use of those for therapeutic and diagnostic purposes
03/27/1991EP0419292A1 Human tryptase-like protein
03/27/1991EP0419252A1 Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
03/27/1991EP0419251A1 Protein-containing aqueous solutions
03/27/1991EP0419182A1 New HCV isolates
03/27/1991EP0419099A1 Proteins having anticoagulant properties
03/27/1991EP0419091A1 Interleukin-4 receptors
03/27/1991EP0418827A1 Vaccine against Lyme disease
03/27/1991EP0418697A1 Pharmaceutical compositions containing calcitonin
03/27/1991EP0418696A2 Derivatives of aminoacids
03/27/1991EP0418642A1 High-absorbable transvaginal preparation containing biologically active peptides
03/27/1991EP0418582A2 Method for treating hypermotility diseases of the bowel employing an ace inhibitor
03/27/1991EP0418365A1 Controlled-action anesthetic compounds and pharmaceutical compositions containing same
03/27/1991EP0418347A1 Human monoclonal antibodies to human immunodeficiency virus
03/27/1991EP0418316A1 Platelet-specific chimeric immunoglobulin
03/27/1991EP0418283A1 Antibodies
03/27/1991EP0418233A1 Cysteine proteinase inhibitor
03/27/1991EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity.
03/27/1991CN1050198A Peptidase and isomerase inhibitors
03/26/1991WO1991004479A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991WO1991004276A1 Isolated, physiologically active human thrombomodulin polypeptide
03/26/1991WO1991004274A1 Method for inhibiting growth of stem cells
03/26/1991US5003048 Solvent extraction to isolate lymphokines used as antitumor agents
03/26/1991US5003046 Monoclonal antibody producing hybridoma and corresponding antibody specific for human breast fibroblast tumor antigen
03/26/1991US5003044 Peptide inhibitors of motor neuron attachment to s-laminin
03/26/1991US5003011 Luteinizing hormone releasing hormone
03/26/1991US5002933 Hexapeptide and medicinal preparation produced from it to treat erosive and ulcerative lesions of gastrointestinal tract
03/26/1991US5002932 Antiviral pharmaceutical compositions and method of treating herpes
03/26/1991US5002931 Human Hypothalmic Growth Hormone Releasing Factor
03/26/1991US5002930 Protein absorption enhancing agents
03/26/1991US5002879 Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor
03/26/1991US5002878 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
03/26/1991US5002873 DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
03/26/1991US5002869 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes
03/26/1991US5002771 Containing caprylic acid monoglyceride to promote adsorption; controll of calcium metabolism
03/26/1991US5002766 Use of catabolic enzymes for controlling the acquired immune deficiency syndrome (AIDS) and its precursors (LAS, ARC)
03/26/1991US5002764 Treatment of actinic keratoses with alpha2 interferon
03/26/1991CA2067123A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991CA2042399A1 Isolated physiologically active human thrombomodulin polypeptide
03/26/1991CA2025960A1 Methods for modulating promoter responsible for beta amyloid precursor protein expression
03/26/1991CA1282069C Antibody complexes of hapten-modified diagnostic or therapeutic agents
03/26/1991CA1282020C Proteins for the production of bioadhesives
03/26/1991CA1282008C Rapid acting intravenous emulsion of omega-3 fatty acid esters
03/26/1991CA1282005C Antiglaucoma compositions and process for their preparation
03/26/1991CA1282002C Pharmaceutical composition comprising t-pa and oxypurinol
03/24/1991WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks
03/24/1991CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks
03/24/1991CA2025941A1 Cns-active hexapeptides with an antiamnesic effect
03/23/1991WO1991004269A1 Medicament comprising antamanide
03/23/1991CA2066721A1 Medicament comprising antamanide
03/23/1991CA2025860A1 Amino acid derivatives
03/23/1991CA2025630A1 Human tryptase-like protein
03/22/1991WO1991004058A2 Treatment of conditions and disease
03/22/1991CA2042034A1 Treatment of conditions and disease
03/21/1991WO1991004329A1 Method of producing fusion proteins
03/21/1991WO1991003569A1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
03/21/1991WO1991003568A1 Brain derived neurotrophic factor
03/21/1991WO1991003562A1 Immunoglobulin-binding polypeptides
03/21/1991WO1991003557A1 Expression of alpha-macroglobulins
03/21/1991WO1991003556A1 Recombinant product
1 ... 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 ... 3163